Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Congestive Heart Failure
Toprol-XL Reduces Hospitalizations, Increases Survival
March 31st, 2000
Adding the beta-blocker Toprol-XL (metoprolol succinate) extended release tablets to standard treatment in patients with congestive heart failure improved survival, reduced hospitalizations, and improved patients' well being, according to the Metoprolol CR/XL (Controlled Release) Randomized Intervention Trial in Heart Failure (MERIT-HF) Study. The study results were published in the March 8, 2000, issue of the Journal of the American Medical Association. MERIT-HF is the largest heart failure trial ever completed evaluating the efficacy of a beta-blocker. Results of MERIT-HF showed a 19% reduction in total mortality or all-cause...
Source: Drug Week (2000-03-31)
|
